PDMR
|
Ordinary Shares granted under the AZDBP
|
Ordinary Shares granted under the AZPSP
|
Award price per Ordinary Share
|
Pascal Soriot
|
17,216
|
97,066
|
£91.54
|
Aradhana Sarin
|
3,249
|
43,038
|
£91.54
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||
a)
|
Name
|
Pascal Soriot
|
|
2
|
Reason for the notification
|
||
a)
|
Position/status
|
Chief Executive Officer
|
|
b)
|
Initial notification /Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
AstraZeneca PLC
|
|
b)
|
LEI
|
PY6ZZQWO2IZFZC3IOL08
|
|
4
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of US$0.25 each in AstraZeneca PLC
GB0009895292
|
|
b)
|
Nature of the transaction
|
Grants of share awards under the AstraZeneca Performance Share Plan
and the AstraZeneca Deferred Bonus Plan
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£91.54
|
114,282
|
||
d)
|
Aggregated information
- Aggregated volume
- Price
|
Not applicable - single transaction
|
|
e)
|
Date of the transaction
|
4 March 2022
|
|
f)
|
Place of the transaction
|
Outside a trading venue
|
1
|
Details of the person discharging managerial responsibilities /
person closely associated
|
||
a)
|
Name
|
Aradhana Sarin
|
|
2
|
Reason for the notification
|
||
a)
|
Position/status
|
Chief Financial Officer
|
|
b)
|
Initial notification/Amendment
|
Initial notification
|
|
3
|
Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
|
||
a)
|
Name
|
AstraZeneca PLC
|
|
b)
|
LEI
|
PY6ZZQWO2IZFZC3IOL08
|
|
4i
|
Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been
conducted
|
||
a)
|
Description of the financial instrument, type of
instrument
Identification code
|
Ordinary Shares of US$0.25 each in AstraZeneca PLC
GB0009895292
|
|
b)
|
Nature of the transaction
|
Grants of share awards under the AstraZeneca Performance Share Plan
and the AstraZeneca Deferred Bonus Plan
|
|
c)
|
Price(s) and volume(s)
|
Price(s)
|
Volume(s)
|
£91.54
|
46,287
|
||
d)
|
Aggregated information
- Aggregated volume
- Price
|
Not applicable - single transaction
|
|
e)
|
Date of the transaction
|
4 March 2022
|
|
f)
|
Place of the transaction
|
Outside a trading venue
|
|
AstraZeneca
PLC
|
|
By: /s/
Adrian Kemp
|
|
Name:
Adrian Kemp
|
|
Title:
Company Secretary
|